BioCryst Pharmaceuticals (BCRX) Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization
High R&D costs and patent protection create a steep barrier to entry in the sector. The EV/EBITDA multiple of this capital-intensive enterprise visualizes this resilience, where the value of 5.88 reflects this status. Standard waste utilization complements the operating model. Sales growth for Orladeyo and new pipeline developments ensure BioCryst (BCRX) transitions toward stable profitability.
biocryst.com - analytical breakdowns and key metrics (BCRX)
- current price and projected stock value:
- market capitalization details:
- book value of equity indicators:
- debt level and financial liquidity data:
- business earnings and investment ratios data:
BCRX - Company Net Income|Projected Future Earnings BioCryst|BCRX - Price to Earnings Ratio|Future Price to Earnings BioCryst|BCRX - Growth-Adjusted Payback Ratio|Enterprise Value to EBITDA Ratio BioCryst Corp|BCRX - Profit before interest, taxes and amortization|Earnings per share for the last twelve months BioCryst|BCRX - Net earnings per share for the last four quarters|Year-over-year net earnings per share growth for the last 12 months biocryst.com|BCRX - Net earnings per one share growth for the current year|Earnings growth forecast for next year BioCryst
Initial company analysis:BioCryst Pharmaceuticals Inc BCRX
BioCryst development of orphan drugs ensures stable demand that remains independent of market cycles and GDP fluctuations. The ratio of total enterprise value to operating profit allows investors to assess the actual return on assets, while the company's current EV/EBITDA value helps identify risks of hidden liquidity shortages masked by the asset's apparent cheapness.
Who BioCryst competes with
EV/EBITDA Multiple ARGX (Argenx)|Total Company Value to Operating Income Before Depreciation Ratio BioNTech Pharma (BNTX)|ABVX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|admabiologics.com (ADMA) - Enterprise Value to EBITDA Ratio|Protagonist (PTGX) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio Immunovant Inc|Enterprise Value to EBITDA Ratio KNSA|EV/EBITDA Multiple Grifols Biemat|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Adaptive Biotechnologies (ADPT)|celldex.com - Enterprise Value to Operating Income Before Depreciation|EV/EBITDA Multiple AUPH (Aurinia Pharmaceuticals Inc.)|Vera Therapeutics Inc (VERA) - Company Value to EBITDA|Dianthus Pharma - EV/EBITDA Multiple|PHVS: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|ABCL: EV/EBITDA Multiple|TRML - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Precigen|Company Value to EBITDA Pharming Group NV PHAR|EV/EBITDA Multiple NKTR|Enterprise Value to EBITDA Ratio Upstream Pharma UPB|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Zenas Biopharma Inc ZBIO|Business Value to Operating Income Before Depreciation IMNM|GOSS: Enterprise Value to EBITDA Ratio|Company Value to EBITDA KalVista Pharma|Septerna Corp (SEPN) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|PVLA - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to EBITDA Ratio SVRA|RIGL (rigel.com) - Enterprise Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple ANAB|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization ATXS (Astria Therapeutics Inc)|EV/EBITDA Multiple ENGN (enGene Bio)|RAPT - Enterprise Value to EBITDA Ratio|JBIO - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Business Value to Operating Income Before Depreciation ACRS (aclaristx.com)|KYTX (Kyverna Therapeutics, Inc.) - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation TLSA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Cabaletta Bio, Inc|Ventyx Biosciences, Inc - Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple THTX|AVTX (avalotx.com) - Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple ELDN (Eledon Pharmaceuticals, Inc.)|EV/EBITDA Multiple Agenus, Inc. AGEN|CLYM - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Business Value to Operating Income Before Depreciation ZURA (zurabio.com)|aTyr Pharma, Inc. (ATYR) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio Adagene Inc.|IMA (ImageneBio) - EV/EBITDA Multiple|EV/EBITDA Multiple Shattuck Therapeutics|Enterprise Value to EBITDA Ratio EQ (Equillium, Inc.)|CNTB (connectbiopharm.com) - Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple IMUX (Immunic)|Total Company Value to Operating Income Before Depreciation Ratio Atara Biotherapeutics, Inc. (ATRA)|IFRX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|X4 Pharmaceuticals Inc. (XFOR) - Enterprise Value to EBITDA Ratio|adicetbio.com (ACET) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio Celularity|Enterprise Value to EBITDA Ratio INMB|EV/EBITDA Multiple barinthusbio.com|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Kezar Life Sciences, Inc. (KZR)|SAB Biotherapeutics Inc. - Enterprise Value to Operating Income Before Depreciation|EV/EBITDA Multiple AKTX (Akari Therapeutics plc)|Enlivex Therapeutics Ltd (ENLV) - Company Value to EBITDA|Q32 Bio Corp - EV/EBITDA Multiple|GOVX: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|EDSA: EV/EBITDA Multiple|IBIO - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Carisma Therapeutics Inc|Company Value to EBITDA XTL Bio XTLB|EV/EBITDA Multiple BOLT|Enterprise Value to EBITDA Ratio hcwbiologics.com HCWB|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Aptevo Therapeutics Inc. APVO|Business Value to Operating Income Before Depreciation AIM|ADTX: Enterprise Value to EBITDA Ratio|Company Value to EBITDA GRI Bio Corporation|XORTX Therapeutics Inc. (XRTX) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|HIND - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to EBITDA Ratio REVB|INDP (Indaptus Therapeutics Inc) - Enterprise Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple SCNI|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization CALI (calcimedica.com)|EV/EBITDA Multiple AFMD (Affimed N.V.)|ALLK - Enterprise Value to EBITDA Ratio|HOOK - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Business Value to Operating Income Before Depreciation IGMS (IGM Biosciences, Inc.)|ITOS (iTeos) - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation OCEA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization TC Biopharm|thirdharmonicbio.com - Company Value to Operating Income Before Depreciation Ratio
